Overview: Aerobic Culture Paired Blood TestIntroduction: The Aerobic Culture Paired Blood Test detects bacteria in paired blood samples, indicating infections causing fever or sepsis. Following 2023 IDSA guidelines, it uses culture techniques for high specificity, aiding in infectious disease screening. This test is critical for guiding diagnosis, treatment, and improving outcomes in bacteriology for patients with suspected bloodstream infections.
Other Names: Paired Blood Culture, Aerobic Blood Culture Test.
FDA Status: Laboratory-developed test (LDT), meeting bacteriology standards for diagnostic accuracy.
Historical Milestone: Blood culture testing began in the 1900s with sepsis research. Paired blood cultures emerged in the 1970s, and by the 2000s, automated systems improved accuracy.
Purpose: Diagnoses bloodstream infections, guides antibiotic therapy, and monitors bacterial presence in patients with fever or sepsis.
Test Parameters: 1. Aerobic Bacteria
Pretest Condition: No fasting required. Collect paired blood samples at any time. Report symptoms like fever or chills, and list recent infections or procedures.
Specimen: 5-10 mL per bottle paired blood (sterile bottle, two sites). Transport in a biohazard bag within 24 hours.
Sample Stability at Room Temperature: 24 hours
Sample Stability at Refrigeration: 48 hours
Sample Stability at Frozen: Not frozen
Medical History: Document fever, chills, or history of infections/procedures. Include current medications, especially antibiotics.
Consent: Written consent required, detailing the tests purpose, diagnostic implications, and potential need for antibiotic therapy.
Procedural Considerations: Uses automated culture systems to detect aerobic bacteria. Results are available in 1-2 days, enabling rapid clinical decisions.
Factors Affecting Result Accuracy: Recent antibiotics or contamination (e.g., skin flora) can affect results. Improper storage reduces sensitivity.
Clinical Significance: Positive culture results confirm bloodstream infection, prompting antibiotic therapy. Negative results may require repeat testing.
Specialist Consultation: Consult an infectious disease specialist for result interpretation. A critical care specialist referral is advised for sepsis cases.
Additional Supporting Tests: Anaerobic blood culture, procalcitonin test, or imaging to confirm infection source.
Test Limitations: False negatives may occur with low bacterial load. Results require clinical correlation.
References: IDSA Sepsis Guidelines, 2023; Clinical Infectious Diseases, Baron EJ, 2022.
